NY A02327

Requires health care plans and utilization review agents to annually report step therapy override request data to state regulators, organized by individual drug name and drug category/class

Mandates public disclosure of step therapy override information on a readily accessible website, including number of requests received, initial denials with reasons, initial approvals, and reversals on internal appeal

Requires insurers and health maintenance organizations to disclose step therapy protocols, override determinations, appeals processes, and clinical review criteria on their websites and upon request to insureds and health care professionals

Prohibits implementation of new or amended step therapy requirements until the insurer's website has been updated to reflect the changes

Requires insurers to provide written notice to impacted insureds and health care professionals at least 60 days before implementing new or amended step therapy protocols or clinical review criteria